Norway· NO-ID_EDEB78BE-0BD5-4335-9651-03BB1E36D3A8
Zevtera
A ceftobiprol medocaril product containing ceftobiprole medocaril sodium, registered in Norway by Basilea Pharmaceutica Deutschland GmbH. The same ATC class is registered in 8 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Ceftobiprol medocaril is registered in 8 of 19 countries.
Countries holding a registration under ATC J01DI01 (ceftobiprol medocaril), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 5 of them publish a price we can compare per daily dose
Ceftobiprol medocaril · ATC J01DI01
8 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Ireland
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
FEST (Norway)- Active substance
- Ceftobiprole Medocaril Sodium
- Manufacturer
- Basilea Pharmaceutica Deutschland GmbH
- Country
- Norway (NO)
- ATC code
- J01DI01
- ATC class
- Ceftobiprol medocaril
- Defined daily dose
- 1.5 g, P
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_EDEB78BE-0BD5-4335-9651-03BB1E36D3A8
- no_varenummer46112210 x 20NOK 6710.4
- gtin7640137531751
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ceftobiprol medocaril in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumMabelio 500 mgBasilea Medical
- FinlandZevteraBasilea Pharmaceutica Deutschland GmbH
- IrelandAdaluzis 500mg Powder for concentrate for solution for infusionAdvanz Pharma Limited
- SwedenZevtera 500 mg Pulver till koncentrat till infusionsvätska, lösningBasilea Pharmaceutica Deutschland GmbH
- United StatesZEVTERALa Jolla Pharmaceutical Company
- GermanyZevteraAdvanz Pharma Limited
- FranceMABELIO 500 mg, poudre pour solution à diluer pour solution pour perfusionADVANZ PHARMA LIMITED
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Austria · Zevtera
- Germany · Zevtera
- Denmark · Zevtera
- Spain · Zevtera
- Finland · Zevtera
- France · Mabelio
- United Kingdom (Northern Ireland) · Zevtera
- Ireland · Adaluzis
- Italy · Mabelio
- Luxembourg · Mabelio, Zevtera
- Poland · Zevtera
- Portugal · Zevtera
- Sweden · Zevtera
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8497e975-8171-42a5-a9eb-fd5fa6ada4d7 GET /v1/drugs/8497e975-8171-42a5-a9eb-fd5fa6ada4d7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Pulver til konsentrat til infusjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Ceftobiprolmedokaril",
"merkevare_id": "ID_EDEB78BE-0BD5-4335-9651-03BB1E36D3A8",
"name_form_strength": "Zevtera pulv til kons til inf væske, oppl 500 mg",
"prescription_group": "C"
}See everything about ceftobiprol medocaril.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.